COVID-19: Caring for Patients and Communities
Seattle’s University of Washington health system, UW Medicine, and its affiliates are sharing resources they developed as the first providers and administrators to encounter COVID-19 on U.S. soil.
An immunologist at Johns Hopkins University (JHU) in Baltimore, Md., is working to develop a blood-derived treatment for use against COVID-19. The technique uses antibodies from the blood plasma or serum of people who have recovered from the infection. If all goes well, the team says, it may be…